Alterity Therapeutics Limited (ATHE)
NASDAQ·Healthcare·Biotechnology
$4.58
-0.89%
Mkt Cap $32.18M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 25, 2026 | $1.07M | $645.88K | -39.60% | -$0.23 | -$0.38 | -65.91% | — | — |
| Q3 2025 Aug 28, 2025 | $5.05M | $3.83M | -24.11% | -$0.43 | -$0.40 | +7.21% | — | — |
| Q1 2025 Feb 28, 2025 | $2.30M | $802.96K | -65.14% | -$0.53 | -$0.00 | +99.87% | — | — |
| Q1 2025 Feb 3, 2025 | — | $802.96K | — | — | -$0.00 | — | — | — |
| Q3 2024 Aug 29, 2024 | $950.00K | $2.12M | +123.01% | -$0.05 | -$0.00 | +96.21% | — | — |
| Q2 2024 Apr 11, 2024 | — | $1.06M | — | — | -$0.00 | — | — | — |
| Q1 2024 Feb 28, 2024 | $958.26K | $1.90M | +98.35% | -$0.11 | -$0.00 | +97.53% | — | — |
| Q1 2024 Jan 30, 2024 | — | $950.36K | — | — | -$0.00 | — | — | — |
| Q2 2023 Jun 30, 2023 | — | $1.53M | — | — | -$0.00 | — | — | — |
| Q1 2023 Mar 31, 2023 | $1.50M | $765.25K | -48.96% | -$0.12 | -$0.00 | +99.01% | — | — |
| Q1 2023 Feb 28, 2023 | $1.82M | $7.67K | -99.58% | -$1.81 | -$1.11 | +38.62% | — | — |
| Q4 2022 Dec 31, 2022 | — | $2.39M | — | — | -$0.00 | — | — | — |
| Q3 2022 Aug 30, 2022 | $2.87M | $1.82M | -36.46% | -$1.97 | -$1.43 | +27.48% | — | — |
| Q2 2022 Jun 30, 2022 | — | $2.76M | — | — | -$0.00 | — | — | — |
| Q1 2022 Feb 28, 2022 | — | $980 | — | — | -$0.98 | — | — | — |
| Q4 2021 Dec 31, 2021 | — | $2.36M | — | — | -$0.00 | — | — | — |
| Q2 2021 Jun 30, 2021 | — | $2.46M | — | — | -$0.00 | — | — | — |
| Q4 2020 Dec 31, 2020 | — | $1.88M | — | — | -$0.01 | — | — | — |
| Q2 2020 Jun 30, 2020 | — | -$1.86M | — | — | -$0.01 | — | — | — |
| Q4 2019 Dec 31, 2019 | — | $1.86M | — | — | -$0.01 | — | — | — |